↓ Skip to main content

Cochrane Database of Systematic Reviews

Buflomedil for intermittent claudication

Overview of attention for article published in Cochrane database of systematic reviews, March 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
89 Mendeley
Title
Buflomedil for intermittent claudication
Published in
Cochrane database of systematic reviews, March 2013
DOI 10.1002/14651858.cd000988.pub4
Pubmed ID
Authors

Tine LM de Backer, Robert Vander Stichele

Abstract

Intermittent claudication (IC) is pain caused by chronic occlusive arterial disease, that develops in a limb during exercise and is relieved with rest. Buflomedil is a vasoactive agent used to treat peripheral vascular disease. However, its clinical efficacy for IC has not yet been critically examined. This is an update of a Cochrane review first published in 2000, and previously updated in 2007 and 2008.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 89 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 19%
Student > Bachelor 13 15%
Researcher 13 15%
Student > Ph. D. Student 12 13%
Other 8 9%
Other 8 9%
Unknown 18 20%
Readers by discipline Count As %
Medicine and Dentistry 30 34%
Nursing and Health Professions 17 19%
Psychology 6 7%
Sports and Recreations 3 3%
Social Sciences 3 3%
Other 11 12%
Unknown 19 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2020.
All research outputs
#9,750,833
of 17,351,915 outputs
Outputs from Cochrane database of systematic reviews
#9,284
of 11,661 outputs
Outputs of similar age
#77,330
of 161,779 outputs
Outputs of similar age from Cochrane database of systematic reviews
#83
of 109 outputs
Altmetric has tracked 17,351,915 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,661 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.0. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,779 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 109 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.